Louis S Matza

Summary

Affiliation: United BioSource Corporation
Country: USA

Publications

  1. pmc Preferences related to attention-deficit/hyperactivity disorder and its treatment
    Kate Van Brunt
    Center for Health Outcomes Research at United BioSource Corporation, Bethesda, MD, USA
    Patient Prefer Adherence 5:33-43. 2011
  2. pmc Validation of a patient interview for assessing reasons for antipsychotic discontinuation and continuation
    Louis S Matza
    Outcomes Research, United BioSource Corporation, Bethesda, MD
    Patient Prefer Adherence 6:521-32. 2012
  3. pmc Health state utilities for skeletal-related events secondary to bone metastases
    Louis S Matza
    Outcomes Research, United BioSource Corporation, 7101 Wisconsin Avenue, Suite 600, Bethesda, MD, 20814, USA
    Eur J Health Econ 15:7-18. 2014
  4. doi Pediatric patient-reported outcome instruments for research to support medical product labeling: report of the ISPOR PRO good research practices for the assessment of children and adolescents task force
    Louis S Matza
    Outcomes Research, United BioSource Corporation, Bethesda, MD 20814, USA
    Value Health 16:461-79. 2013
  5. pmc The Fatigue Associated with Depression Questionnaire (FAsD): responsiveness and responder definition
    Louis S Matza
    Outcomes Research, United BioSource Corporation, 7101 Wisconsin Avenue, Suite 600, Bethesda, MD 20814, USA
    Qual Life Res 22:351-60. 2013
  6. doi Validation of a clinician questionnaire to assess reasons for antipsychotic discontinuation and continuation among patients with schizophrenia
    Louis S Matza
    Outcomes Research, United BioSource Corporation, Bethesda, MD 20814, USA
    Psychiatry Res 200:835-42. 2012
  7. pmc Patient-reported outcome instruments used to assess pain and functioning in studies of bisphosphonate treatment for bone metastases
    Louis S Matza
    United BioSource Corporation, 7101 Wisconsin Ave, Suite 600, Bethesda, MD 20814, USA
    Support Care Cancer 20:657-77. 2012
  8. pmc Patient-reported outcomes in a trial of exenatide and insulin glargine for the treatment of type 2 diabetes
    Kristina Secnik Boye
    Eli Lilly and Company, Indianapolis, IN 46285, USA
    Health Qual Life Outcomes 4:80. 2006
  9. doi Identifying HAM-A cutoffs for mild, moderate, and severe generalized anxiety disorder
    Louis S Matza
    Center for Health Outcomes Research, United BioSource Corporation, Bethesda, MD 20814, USA
    Int J Methods Psychiatr Res 19:223-32. 2010
  10. ncbi Utilities and disutilities for type 2 diabetes treatment-related attributes
    Louis S Matza
    Center for Health Outcomes Research, United BioSource Corporation, 7101 Wisconsin Ave, Suite 600, Bethesda, MD 20814, USA
    Qual Life Res 16:1251-65. 2007

Detail Information

Publications49

  1. pmc Preferences related to attention-deficit/hyperactivity disorder and its treatment
    Kate Van Brunt
    Center for Health Outcomes Research at United BioSource Corporation, Bethesda, MD, USA
    Patient Prefer Adherence 5:33-43. 2011
    ..The purpose of the current review was to identify and summarize published research on preferences related to attention-deficit/hyperactivity disorder (ADHD) and its treatment, while suggesting directions for future research...
  2. pmc Validation of a patient interview for assessing reasons for antipsychotic discontinuation and continuation
    Louis S Matza
    Outcomes Research, United BioSource Corporation, Bethesda, MD
    Patient Prefer Adherence 6:521-32. 2012
    ....
  3. pmc Health state utilities for skeletal-related events secondary to bone metastases
    Louis S Matza
    Outcomes Research, United BioSource Corporation, 7101 Wisconsin Avenue, Suite 600, Bethesda, MD, 20814, USA
    Eur J Health Econ 15:7-18. 2014
    ..The purpose of this study was to estimate the disutility of four SREs: spinal cord compression, pathological fracture, radiation to bone, and surgery performed to stabilize a bone...
  4. doi Pediatric patient-reported outcome instruments for research to support medical product labeling: report of the ISPOR PRO good research practices for the assessment of children and adolescents task force
    Louis S Matza
    Outcomes Research, United BioSource Corporation, Bethesda, MD 20814, USA
    Value Health 16:461-79. 2013
    ..Patient-reported outcome (PRO) instruments for children and adolescents are often included in clinical trials with the intention of collecting data to support claims in a medical product label...
  5. pmc The Fatigue Associated with Depression Questionnaire (FAsD): responsiveness and responder definition
    Louis S Matza
    Outcomes Research, United BioSource Corporation, 7101 Wisconsin Avenue, Suite 600, Bethesda, MD 20814, USA
    Qual Life Res 22:351-60. 2013
    ..The purpose of this study was to examine the questionnaire's responsiveness to change and identify a responder definition for interpretation of treatment-related changes...
  6. doi Validation of a clinician questionnaire to assess reasons for antipsychotic discontinuation and continuation among patients with schizophrenia
    Louis S Matza
    Outcomes Research, United BioSource Corporation, Bethesda, MD 20814, USA
    Psychiatry Res 200:835-42. 2012
    ..Findings indicate that clinicians usually report multiple reasons for discontinuation, rather than a single reason for each patient...
  7. pmc Patient-reported outcome instruments used to assess pain and functioning in studies of bisphosphonate treatment for bone metastases
    Louis S Matza
    United BioSource Corporation, 7101 Wisconsin Ave, Suite 600, Bethesda, MD 20814, USA
    Support Care Cancer 20:657-77. 2012
    ..The goal of the current review was to examine measures used to assess pain, as well as the impact of pain on functional status and health-related quality of life (HRQL), in trials of bisphosphonates for the treatment of bone metastases...
  8. pmc Patient-reported outcomes in a trial of exenatide and insulin glargine for the treatment of type 2 diabetes
    Kristina Secnik Boye
    Eli Lilly and Company, Indianapolis, IN 46285, USA
    Health Qual Life Outcomes 4:80. 2006
    ....
  9. doi Identifying HAM-A cutoffs for mild, moderate, and severe generalized anxiety disorder
    Louis S Matza
    Center for Health Outcomes Research, United BioSource Corporation, Bethesda, MD 20814, USA
    Int J Methods Psychiatr Res 19:223-32. 2010
    ..These cutoffs should be used with caution and validated in larger samples. If the proposed cutoffs are accepted for general use, they could make results more meaningful and interpretable for researchers, clinicians, and patients...
  10. ncbi Utilities and disutilities for type 2 diabetes treatment-related attributes
    Louis S Matza
    Center for Health Outcomes Research, United BioSource Corporation, 7101 Wisconsin Ave, Suite 600, Bethesda, MD 20814, USA
    Qual Life Res 16:1251-65. 2007
    ..The purpose of this study was to identify the utility or disutility of diabetes medication-related attributes (weight change, gastrointestinal side effects, fear of hypoglycemia) that may influence patient preference...
  11. ncbi Obese versus non-obese patients with type 2 diabetes: patient-reported outcomes and utility of weight change
    Louis S Matza
    Center for Health Outcomes Research at UBC, Bethesda, MD 20814, USA
    Curr Med Res Opin 23:2051-62. 2007
    ....
  12. pmc Validation of two generic patient-reported outcome measures in patients with type 2 diabetes
    Louis S Matza
    Center for Health Outcomes Research at United BioSource Corporation, Bethesda, MD, USA
    Health Qual Life Outcomes 5:47. 2007
    ..Prior to using a generic patient-reported outcome measure (PRO), the measure should be validated within the target population. The purpose of the current study was to validate two generic measures in patients with type 2 diabetes...
  13. ncbi Responsiveness of the Adult Attention-Deficit/Hyperactivity Disorder Quality of Life Scale (AAQoL)
    Louis S Matza
    Center for Health Outcomes Research at UBC, 7101 Wisconsin Avenue, Suite 600, Bethesda, MD 20814, USA
    Qual Life Res 16:1511-20. 2007
    ....
  14. ncbi Further testing of the reliability and validity of the ASK-20 adherence barrier questionnaire in a medical center outpatient population
    Louis S Matza
    Center for Health Outcomes Research, United BioSource Corporation, Bethesda, MD, USA
    Curr Med Res Opin 24:3197-206. 2008
    ..This study examined the psychometric properties of the ASK-20 questionnaire, which was developed to assess barriers to medication adherence...
  15. doi Development and validation of a patient-report measure of fatigue associated with depression
    Louis S Matza
    Center for Health Outcomes Research, United BioSource Corporation, Bethesda, MD, United States
    J Affect Disord 134:294-303. 2011
    ..Thus, the purpose of the current study was to develop and validate a patient-reported outcome measure designed to assess depression-related fatigue and its impact...
  16. ncbi Impact of atomoxetine on health-related quality of life and functional status in patients with ADHD
    Louis S Matza
    Center for Health Outcomes Research at UBC, 7101 Wisconsin Avenue, Suite 600 Bethesda, MD 20814, USA
    Expert Rev Pharmacoecon Outcomes Res 6:379-90. 2006
    ..Studies with active comparators are needed to determine whether the health-related quality of life benefits of atomoxetine are superior or comparable to those of stimulant medications...
  17. doi Development of a clinician questionnaire and patient interview to assess reasons for antipsychotic discontinuation
    Louis S Matza
    Center for Health Outcomes Research, United BioSource Corporation, Bethesda, MD, USA
    Psychiatry Res 189:463-8. 2011
    ..The RAD-Q and RAD-I appear to be useful instruments for assessing reasons for antipsychotic discontinuation and continuation. The next step is a psychometric evaluation of the measures in a larger sample...
  18. doi Test-retest reliability of two patient-report measures for use in adults with ADHD
    Louis S Matza
    Center for Health Outcomes Research, United BioSource Corporation, Bethesda, MD, USA
    J Atten Disord 15:557-63. 2011
    ..The purpose of the current analysis was to assess test-retest reliability of two measures designed specifically for adults with ADHD: the Adult ADHD Self-Report Screener (ASRS) and the Adult ADHD Quality of Life Measure (AAQoL)...
  19. doi Derivation and validation of the ASK-12 adherence barrier survey
    Louis S Matza
    Center for Health Outcomes Research, United BioSource Corporation, Bethesda, MD 20814, USA
    Ann Pharmacother 43:1621-30. 2009
    ..The ASK-20 survey is a previously validated patient-report measure of barriers to medication adherence and adherence-related behavior...
  20. ncbi Efficacy of olanzapine and ziprasidone for the treatment of schizophrenia: a systematic review
    Louis S Matza
    The MEDTAP Institute at UBC, Bethesda, Maryland 20814, USA
    CNS Drugs 19:499-515. 2005
    ..Firm conclusions regarding the comparison between olanzapine and ziprasidone require additional published trials on ziprasidone, particularly in direct comparison with olanzapine...
  21. pmc Measuring changes in functional status among patients with schizophrenia: the link with cognitive impairment
    Louis S Matza
    Center for Health Outcomes Research at UBC, 7101 Wisconsin Ave, Suite 600, Bethesda, MD 20814, USA
    Schizophr Bull 32:666-78. 2006
    ..When creating new functional outcomes measures for assessment of patients with schizophrenia, responsiveness to change in CIAS should be evaluated as part of the development and validation process...
  22. pmc The longitudinal link between visual acuity and health-related quality of life in patients with diabetic retinopathy
    Louis S Matza
    Center for Health Outcomes Research, United BioSource Corporation, Bethesda, MD 20814, USA
    Health Qual Life Outcomes 6:95. 2008
    ..This study characterized the degree of change in health-related quality of life (HRQL) associated with change in visual acuity among patients with diabetic retinopathy...
  23. ncbi Parent-proxy EQ-5D ratings of children with attention-deficit hyperactivity disorder in the US and the UK
    Louis S Matza
    The MEDTAP Institute at United BioSource Corporation UBC, Bethesda, MD 20814, USA
    Pharmacoeconomics 23:777-90. 2005
    ..The objective of this study was to assess the HR-QOL of children with ADHD using parents' responses to the proxy version of the EQ-5D...
  24. ncbi Misdiagnosed patients with bipolar disorder: comorbidities, treatment patterns, and direct treatment costs
    Louis S Matza
    The MEDTAP Institute at UBC, 7101 Wisconsin Avenue, Suite 600, Bethesda, MD 20814, USA
    J Clin Psychiatry 66:1432-40. 2005
    ..The purpose of this study was to examine comorbidities, treatment patterns, and direct treatment costs of patients with bipolar disorder who are misdiagnosed with unipolar depression...
  25. ncbi Assessment of health state utilities for attention-deficit/hyperactivity disorder in children using parent proxy report
    Louis S Matza
    MEDTAP International, Inc, Center for Health Outcomes Research, Bethesda, MD 20814, USA
    Qual Life Res 14:735-47. 2005
    ..03). Results suggest that parent SG interviews are a feasible and useful method for obtaining utility scores that can be used in cost-effectiveness models of ADHD treatment...
  26. ncbi The patient experience of depression and remission: focus group results
    Lori Frank
    Center for Health Outcomes Research, United BioSource Corporation, Bethesda, Maryland, USA biosource com
    J Nerv Ment Dis 195:647-54. 2007
    ..Results suggest that new measures of treatment outcome should encompass irritability, anger, and ability to cope with life stressors...
  27. ncbi Validation of a new symptom impact questionnaire for mild to moderate cognitive impairment
    Lori Frank
    The MEDTAP Institute at UBC, Bethesda, MD 20814, USA
    Int Psychogeriatr 18:135-49. 2006
    ....
  28. ncbi Psychometric validation of the child health questionnaire (CHQ) in a sample of children and adolescents with attention-deficit/hyperactivity disorder
    Anne M Rentz
    Center for Health Outcomes Research, MEDTAP International, Bethesda, MD 20814, USA
    Qual Life Res 14:719-34. 2005
    ..Study results indicate the CHQ-PF50 is reliable, valid, and responsive to change in ADHD symptoms, suggesting it may provide a means of assessing HRQL outcomes associated with treatments for ADHD...
  29. doi The psychometric validation of the OAB family impact measure (OAB-FIM)
    Karin S Coyne
    United BioSource Corporation, Bethesda, Maryland 20814, USA
    Neurourol Urodyn 29:359-69. 2010
    ..Presently, no validated instruments exist to assess family impact, thus we examined the psychometric properties of a new instrument, the overactive bladder family impact measure (OAB-FIM)...
  30. ncbi The link between health-related quality of life and clinical symptoms among children with attention-deficit hyperactivity disorder
    Louis S Matza
    MEDTAP International, Inc, Bethesda, Maryland, USA
    J Dev Behav Pediatr 25:166-74. 2004
    ..The findings suggest that HRQL instruments can add important information to efficacy measures in clinical trials of ADHD treatment...
  31. ncbi The responsiveness of the OAB-q among OAB patient subgroups
    Karin S Coyne
    Center for Health Outcomes Research, United BioSource Corporation, 7101 Wisconsin Avenue, Bethesda, MD 20814, USA
    Neurourol Urodyn 26:196-203. 2007
    ..The purpose of this analysis was to assess the responsiveness of the OAB-q among OAB patient subgroups with a focus on continent patients...
  32. ncbi Assessment of health-related quality of life in children: a review of conceptual, methodological, and regulatory issues
    Louis S Matza
    MEDTAP International Inc, Bethesda, MD 20814, USA
    Value Health 7:79-92. 2004
    ..a recommendation for additional research on the HRQL impact of childhood psychiatric disorders. It is advocated that assessment of HRQL among children should be conducted regularly as an integral part of drug development...
  33. ncbi Test-retest reliability of four questionnaires for patients with overactive bladder: the overactive bladder questionnaire (OAB-q), patient perception of bladder condition (PPBC), urgency questionnaire (UQ), and the primary OAB symptom questionnaire (POSQ)
    Louis S Matza
    MEDTAP International, Inc, Bethesda, Maryland 20814, USA
    Neurourol Urodyn 24:215-25. 2005
    ....
  34. ncbi Impact of cognitive impairment on mild dementia patients and mild cognitive impairment patients and their informants
    Lori Frank
    The MEDTAP Institute at UBC, Bethesda, MD 20814, USA
    Int Psychogeriatr 18:151-62. 2006
    ....
  35. ncbi Depression with atypical features in the National Comorbidity Survey: classification, description, and consequences
    Louis S Matza
    MEDTAP International, Inc, Bethesda, MD 20814, USA
    Arch Gen Psychiatry 60:817-26. 2003
    ..The current study was conducted to increase understanding of atypical depression diagnosed using only the reversed vegetative symptoms of hypersomnia and hyperphagia...
  36. ncbi The responsiveness of the Overactive Bladder Questionnaire (OAB-q)
    Karin S Coyne
    MEDTAP International, Inc, Center for Health Outcomes Research, 7101 Wisconsin Avenue, Suite 600, Bethesda, MD 20814, USA
    Qual Life Res 14:849-55. 2005
    ..The purpose of this study was to examine the responsiveness of the Overactive Bladder questionnaire (OAB-q) during anti-muscarinic treatment...
  37. ncbi Depression and health-related quality of life for low-income African-American women in the U.S
    Lori B Frank
    Center for Health Outcomes Research, The MEDTAP Institute at UBC, 7101 Bethesda, MD, USA
    Qual Life Res 14:2293-301. 2005
    ..Results indicate the substantial HRQL impact of depression among low-income young African-American women with depression...
  38. doi Examining lower urinary tract symptom constellations using cluster analysis
    Karin S Coyne
    Center for Health Outcomes Research, United BioSource Corporation, Bethesda, MD 20814, USA
    BJU Int 101:1267-73. 2008
    ..To gain a better understanding of how patients experience lower urinary tract symptoms (LUTS) and to determine whether particular symptoms cluster together, as LUTS seldom occur alone...
  39. ncbi Determining the importance of change in the overactive bladder questionnaire
    Karin S Coyne
    United BioSource Corporation Center for Health Outcomes Research, Bethesda, Maryland 20814, USA
    J Urol 176:627-32; discussion 632. 2006
    ..It has been shown to be reliable, valid and responsive. We established the minimally important difference of the overactive bladder questionnaire...
  40. pmc Impact of caregiver and parenting status on time trade-off and standard gamble utility scores for health state descriptions
    Louis S Matza
    Senior Research Scientist, Outcomes Research, Evidera, Bethesda, MD, USA
    Health Qual Life Outcomes 12:48. 2014
    ..Respondents were categorized as caregivers if they reported that either children or adults depended on them for care...
  41. ncbi Bipolar disorder and health-related quality of life : review of burden of disease and clinical trials
    Dennis A Revicki
    Center for Health Outcomes Research, The MEDTAP Institute at United BioSource Corporation, Bethesda, Maryland 20814, USA biosource com
    Pharmacoeconomics 23:583-94. 2005
    ..HR-QOL outcome data may be useful in informing psychiatrists, patients and patient family members of the effects of treatment for bipolar disorder on patients' everyday lives, functioning and wellbeing...
  42. ncbi Patient and caregiver perspective on pediatric eosinophilic esophagitis and newly developed symptom questionnaires*
    Emuella M Flood
    Oxford Outcomes Inc, Bethesda, MD 20814, USA
    Curr Med Res Opin 24:3369-81. 2008
    ..The questionnaires were developed based on a review of the literature and clinical expert consultation...
  43. ncbi Cost-effectiveness of intrathecal baclofen therapy for the treatment of severe spasticity associated with cerebral palsy
    Gregory de Lissovoy
    United BioSource Corporation, 7101 Wisconsin Avenue, Suite 600, Bethesda, MD 20814, USA
    J Child Neurol 22:49-59. 2007
    ..The net result was an incremental cost-effectiveness ratio of $42 000 per quality-adjusted life-year, a figure well within the $50 000 to $100 000 range that is widely accepted as offering good value for the money...
  44. ncbi "We have to stop again?!": The impact of overactive bladder on family members
    Karin S Coyne
    Centerfor Health Outcomes Research, United BioSource Corporation, 7101 Wisconsin Ave Suite 600, Bethesda, MD 20814, USA
    Neurourol Urodyn 28:969-75. 2009
    ..Given the social context inherent in OAB, the purpose of this study was to identify issues faced by OAB family members...
  45. ncbi A review of quality-of-life questionnaires for urinary incontinence and overactive bladder: which ones to use and why?
    Louis S Matza
    MEDTAP International, Inc, Bethesda, MD 20814, USA
    Curr Urol Rep 5:336-42. 2004
    ..Recommendations are provided regarding which measures to use in different situations. When choosing among instruments, psychometric evidence and the match of an instrument to the study population should be considered...
  46. ncbi The validation of the patient perception of bladder condition (PPBC): a single-item global measure for patients with overactive bladder
    Karin S Coyne
    United BioSource Corporation, Center for Health Outcomes Research, Bethesda, MD 20814, USA
    Eur Urol 49:1079-86. 2006
    ..The purpose of this study was to evaluate the validity and responsiveness of a global measure for overactive bladder (OAB), the Patient Perception of Bladder Condition (PPBC)...
  47. ncbi Health state utilities for childhood attention-deficit/hyperactivity disorder based on parent preferences in the United kingdom
    Kristina Secnik
    Eli Lilly and Company, Indianapolis, Indiana 46285, USA
    Med Decis Making 25:56-70. 2005
    ..The purpose of this study was to use standard gamble (SG) utility interviews to assess parent preferences for health states of childhood attention-deficit/hyperactivity disorder (ADHD)...